Michael G. Kaplitt, MD, PhD

About Me

I am a neurosurgeon with clinical activities focused upon the usage of minimally invasive, stereotactic techniques for the treatment of functional disorders such as Parkinson’s disease, essential tremor, and epilepsy. I also use surgical methods to implant devices such as spinal cord stimulators and opiate pumps to treat complex pain, and I am a expert in the treatment of trigeminal neuralgia and hydrocephalus.

I have pioneered the use of gene therapy in the brain and have published more than 40 papers and edited two books on this subject. I recently completed the first clinical trial of gene therapy for Parkinson’s disease for FDA approval, and my laboratory is actively researching mechanisms of cell death in diseases such as Parkinson’s and Huntington’s.

I am the recipient of numerous awards, including the Young Investigator Award from the American Society for Gene Therapy and was named to Crain’s “40 under 40” list for 2004. I currently serve on the editorial boards of several journals, and am the editor for the Web site of the World Society for Stereotactic and Functional Neurosurgery. I am also a member of the Committee on Admissions at Weill Cornell Medical College and am an adjunct professor at The Rockefeller University.

  • Clinical Expertise: Molecular Medicine; Movement Disorders; Spinal Opiate Catheter Implants; Spinal Cord Stimulator Implants; Parkinson's Disease; Trigeminal Neuralgia Surgery
  • Languages Spoken: English
  • Education: MD, Cornell University
  • Residencies: Neurosurgery - New York Hospital
  • Fellowships: Stereotactic and Functional Neurosurgery - University of Toronto
  • Board Certifications: Neurological Surgery

See My Colleagues


Visit PubMed for a full listing of Michael G. Kaplitt’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.